GlassScriptPhysician profile
Jillian R Conner
NPI 1750732335
$3,321.67
in general payments reported to CMS, 2019-2025
41 companies · $830 in 2025
The $830 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $13.23 · 2023: $1,298 · 2024: $1,180 · 2025: $830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,304 · Consulting Fee: $750 · Education: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,304.46 |
| Consulting Fee | $750.00 |
| Education | $253.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $750.00 | 2023 | Rybrevant |
| E.R. Squibb & Sons, L.L.C. | $275.07 | 2023-2025 | Reblozyl, Opdivo |
| Novartis Pharmaceuticals Corporation | $248.74 | 2023-2025 | |
| Daiichi Sankyo INC. | $243.87 | 2024-2025 | Enhertu, Datroway |
| Incyte Corporation | $227.00 | 2023-2024 | Jakafi |
| Genmab U.S., INC. | $187.29 | 2023-2025 | Tivdak, Epkinly |
| Beigene USA, INC. | $156.57 | 2023 | Brukinsa |
| Pfizer INC. | $147.44 | 2023-2025 | |
| Pharmacosmos Therapeutics INC. | $145.48 | 2023-2025 | Monoferric |
| Janssen Biotech, INC. | $96.21 | 2023-2025 | Darzalex, Talvey, Tecvayli |
| Abbvie INC. | $95.94 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $72.28 | 2024-2025 | Fruzaqla, Ninlaro, Alunbrig |
| Merck Sharp & Dohme LLC | $63.87 | 2023-2024 | Keytruda, Lynparza |
| Genentech USA, INC. | $54.20 | 2024-2025 | Polivy, Tecentriq, Columvi |
| Mirati Therapeutics, INC. | $48.90 | 2024 | Krazati |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Conner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.